Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$981M |
| 2 |
Apple
AAPL
|
+$704M |
| 3 |
Amazon
AMZN
|
+$670M |
| 4 |
Merck
MRK
|
+$431M |
| 5 |
NVIDIA
NVDA
|
+$414M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$441M |
| 2 |
JD.com
JD
|
+$196M |
| 3 |
Aon
AON
|
+$184M |
| 4 |
VER
VEREIT, Inc.
VER
|
+$165M |
| 5 |
Dell
DELL
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.2% |
| 2 | Healthcare | 13.25% |
| 3 | Financials | 13.01% |
| 4 | Consumer Discretionary | 11.99% |
| 5 | Communication Services | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBCH
2801
Turtle Beach Corp
TBCH
$269M
| $5.91M | ﹤0.01% |
265,305
+53
| +0% | +$1.43K |
|
|
AFMD
2802
DELISTED
Affimed
AFMD
| $5.9M | ﹤0.01% |
106,965
-132
| -0.1% | -$8.16K |
|
2803
Alto Ingredients
ALTO
$392M
| $5.9M | ﹤0.01% |
1,227,061
-93,036
| -7% | -$488K |
|
2804
Cue Biopharma
CUE
$112M
| $5.9M | ﹤0.01% |
17,380
-2,700
| -13% | -$1.04M |
|
2805
indie Semiconductor
INDI
$716M
| $5.9M | ﹤0.01% |
491,854
-1,360
| -0.3% | -$17.3K |
|
2806
Expensify
EXFY
$195M
| $5.89M | ﹤0.01% |
+133,795
| New | +$5.45M |
|
|
AERI
2807
DELISTED
Aerie Pharmaceuticals
AERI
| $5.88M | ﹤0.01% |
838,313
+184,703
| +28% | +$1.93M |
|
2808
Aveanna Healthcare
AVAH
$2.03B
| $5.88M | ﹤0.01% |
794,467
+11,667
| +1% | +$84.8K |
|
2809
Seneca Foods Class A
SENEA
$1.16B
| $5.88M | ﹤0.01% |
122,588
-478
| -0.4% | -$23.5K |
|
2810
Janus International
JBI
$769M
| $5.86M | ﹤0.01% |
468,166
+14,994
| +3% | +$192K |
|
|
TRHC
2811
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $5.86M | ﹤0.01% |
390,584
+5,354
| +1% | +$97.5K |
|
2812
GeneDx Holdings
WGS
$2.08B
| $5.85M | ﹤0.01% |
39,741
+3,472
| +10% | +$776K |
|
2813
Century Casinos
CNTY
$33.5M
| $5.83M | ﹤0.01% |
478,736
-2,156
| -0.4% | -$30.3K |
|
|
DIDI
2814
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
| $5.83M | ﹤0.01% |
1,177,719
+84,444
| +8% | +$641K |
|
2815
Altimmune
ALT
$589M
| $5.8M | ﹤0.01% |
633,044
-25,808
| -4% | -$274K |
|
2816
Cytek Biosciences
CTKB
$540M
| $5.79M | ﹤0.01% |
355,140
+34,032
| +11% | +$713K |
|
|
HRT
2817
DELISTED
HireRight Holdings Corporation
HRT
| $5.77M | ﹤0.01% |
+360,665
| New | +$6.03M |
|
|
MYOV
2818
DELISTED
Myovant Sciences Ltd.
MYOV
| $5.77M | ﹤0.01% |
370,606
+8,800
| +2% | +$168K |
|
2819
Phathom Pharmaceuticals
PHAT
$666M
| $5.77M | ﹤0.01% |
293,198
+9,335
| +3% | +$220K |
|
2820
Novartis
NVS
$294B
| $5.75M | ﹤0.01% |
65,680
-1,277
| -2% | -$106K |
|
2821
Dyne Therapeutics
DYN
$4.89B
| $5.74M | ﹤0.01% |
482,946
+67,422
| +16% | +$948K |
|
2822
Aemetis
AMTX
$109M
| $5.73M | ﹤0.01% |
466,257
+7,110
| +2% | +$126K |
|
2823
Peoples Financial Services
PFIS
$716M
| $5.73M | ﹤0.01% |
108,820
+602
| +0.6% | +$29.1K |
|
2824
Alkami Technology
ALKT
$2.01B
| $5.72M | ﹤0.01% |
285,234
+167,978
| +143% | +$4.3M |
|
|
GNTY
2825
DELISTED
Guaranty Bancshares
GNTY
| $5.72M | ﹤0.01% |
152,107
+3,310
| +2% | +$124K |
|
Similar funds
Geode Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Geode Capital Management held 5,071 positions worth $830B, up 12% from $743B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Geode Capital Management's Q4 2021 filing shows 216 new, 2,976 increased, 1,070 reduced and 95 closed positions. Its largest new stake was Rivian: 2,078,098 shares worth $215M. The largest sale was Kansas City Southern, an estimated $441M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q4 2021 buy was Rivian: 2,078,098 shares worth $215M.
- Geode Capital Management added most to Microsoft in Q4 2021, an estimated $981M increase.
- Geode Capital Management's biggest Q4 2021 reduction was JD.com, cutting an estimated $196M.
- Geode Capital Management fully exited Kansas City Southern in Q4 2021, selling an estimated $441M.
- Geode Capital Management's ten largest holdings make up 24% of its $830B portfolio in Q4 2021.
- Geode Capital Management opened 216 new positions and closed 95 in Q4 2021.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $830B.
Based on Geode Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.